These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2803542)

  • 1. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior.
    Kelley AE; Gauthier AM; Lang CG
    Behav Brain Res; 1989 Oct; 35(1):27-39. PubMed ID: 2803542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal modulation of nucleus accumbens: behavioral evidence from amphetamine-induced activity profiles.
    Whishaw IQ; Mittleman G
    Behav Neural Biol; 1991 May; 55(3):289-306. PubMed ID: 1905533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions.
    Kelley AE; Delfs JM
    Psychopharmacology (Berl); 1991; 103(2):187-96. PubMed ID: 2027920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor activation by amphetamine infusion into nucleus accumbens core and shell subregions of rats differentially sensitive to dopaminergic drugs.
    West CH; Boss-Williams KA; Weiss JM
    Behav Brain Res; 1999 Jan; 98(1):155-65. PubMed ID: 10210531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin.
    Hernandez L; Lee F; Hoebel BG
    Brain Res Bull; 1987 Dec; 19(6):623-8. PubMed ID: 2449936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical examination of the effects of sensitisation on the mesotelencephalic dopaminergic response to d-amphetamine.
    Phillips GD; Setzu E; Vugler A; Hitchcott PK
    Neuroscience; 2003; 117(3):741-53. PubMed ID: 12617978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding stimulated by very low doses of d-amphetamine administered systemically or by microinjection into the striatum.
    Winn P; Williams SF; Herberg LJ
    Psychopharmacology (Berl); 1982; 78(4):336-41. PubMed ID: 6818595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
    Becker JB; Cha JH
    Behav Brain Res; 1989 Nov; 35(2):117-25. PubMed ID: 2818831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens.
    Hooks MS; Jones DN; Justice JB; Holtzman SG
    Pharmacol Biochem Behav; 1992 Aug; 42(4):765-70. PubMed ID: 1513859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does cyclo(His-Pro) act like amphetamine?
    Mizuma H; Shimizu I; Hilton C; Prasad C
    Life Sci; 1994; 54(21):1625-33. PubMed ID: 8196482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME
    Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.